AURA-MARIE PAWLEY: Open Payments
NPI 1639207400 · SAN MARINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 58 payments from 19 companies in 2025. Trend: 2023 $500 · 2024 $1,301 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $177 |
| Vanda Pharmaceuticals Inc. | 4 | $123 |
| Axsome Therapeutics, Inc. | 5 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $112 |
| Janssen Pharmaceuticals, Inc | 3 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $85 |
| Bausch Health US, LLC | 4 | $81 |
| Neurocrine BioSciences, Inc. | 3 | $80 |
| Teva Pharmaceuticals USA, Inc. | 3 | $67 |
| Alkermes, Inc. | 2 | $59 |
Products named: VRAYLAR, HETLIOZ, CAPLYTA, REXULTI, INVEGA SUSTENNA, COBENFY, APLENZIN, Auvelity.
Industry payments across CA — which companies pay providers there.
